StockData
Apyx Medical Corp logo

Apyx Medical Corp (APYX) stock

APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/3035% above fair value
$2.89−0.11 (-3.67%)

Close on Nov 12, 2026Market cap $121.74MP/E –Yield –

Apyx Medical total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Apyx Medical's total debt was $35.57M at Sep 30, 2026. For fiscal 2025 it was $34.85M, up 2.8% from the year before. The highest annual figure on record is $34.85M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$34.85M+2.8%
FY2024Dec 31, 2024$33.89M+2.1%
FY2023Dec 31, 2023$33.19M–
FY2022Dec 31, 2022$0-100.0%
FY2018Dec 31, 2018$140.00K-94.8%
FY2017Dec 31, 2017$2.69M-8.1%
FY2016Dec 31, 2016$2.93M-7.6%
FY2015Dec 31, 2015$3.17M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$35.57M+2.8%
Q2 FY2026Jun 30, 2026$35.33M+2.8%
Q1 FY2026Mar 31, 2026$35.09M+2.8%
Q4 FY2025Dec 31, 2025$34.85M+2.8%
Q3 FY2025Sep 30, 2025$34.61M+2.2%
Q2 FY2025Jun 30, 2025$34.37M+2.2%
Q1 FY2025Mar 31, 2025$34.13M+2.2%
Q4 FY2024Dec 31, 2024$33.89M+2.1%
Q3 FY2024Sep 30, 2024$33.85M+275.8%
Q2 FY2024Jun 30, 2024$33.63M+278.2%
Q1 FY2024Mar 31, 2024$33.41M+280.6%
Q4 FY2023Dec 31, 2023$33.19M–
Q3 FY2023Sep 30, 2023$9.01M+6335.0%
Q2 FY2023Jun 30, 2023$8.89M+6251.4%
Q1 FY2023Mar 31, 2023$8.78M+6170.0%
Q4 FY2022Dec 31, 2022$0-100.0%
Q3 FY2019Sep 30, 2019$140.00K–
Q2 FY2019Jun 30, 2019$140.00K-94.6%
Q1 FY2019Mar 31, 2019$140.00K-94.7%
Q4 FY2018Dec 31, 2018$140.00K-94.8%
Q3 FY2018Sep 30, 2018$0-100.0%
Q2 FY2018Jun 30, 2018$2.57M-8.5%
Q1 FY2018Mar 31, 2018$2.63M-8.4%
Q4 FY2017Dec 31, 2017$2.69M-8.1%
Q3 FY2017Sep 30, 2017$2.75M–
Q2 FY2017Jun 30, 2017$2.81M–
Q1 FY2017Mar 31, 2017$2.87M–
Q4 FY2016Dec 31, 2016$2.93M–

More Apyx Medical figures

See a number that looks wrong?